FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
This is the first update to the original CTS communication distributed on July 6th. As previously co...
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
On February 18, 2019, the new CTS Laboratory Information System was successfully implemented in Tamp...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...